Today, our family of companies gathered for a Doc Talk lunch and learn! We are proud to partner with the American Heart Association to invite cardiologists to share their expertise about heart health. We were joined by Dr. Yazan Khatib, president of the First Coast Cardiovascular Institute, who spoke with US about peripheral artery disease, its risk factors for diabetics and why it’s so important to practice cardiovascular disease prevention. Thank you for joining US today, Dr. Khatib!
GuideWell Source’s Post
More Relevant Posts
-
The first patient-led global manifesto calling for early detection and diagnosis of cardiovascular disease is available now, and The Mended Hearts, Inc. was delighted to contribute! “Achieving early detection and diagnosis of cardiovascular disease: A manifesto for change” was developed by Global Heart Hub - via a multi-stakeholder approach, bringing together 125 patient advocates including 40 cardiovascular disease patient organizations, key opinion leaders, and multidisciplinary experts from across the world. The landmark manifesto calls on policymakers to implement eight practical evidence-based actions to ensure early detection and diagnosis of cardiovascular disease. Learn more at the link below⬇️ https://lnkd.in/gMyRDXYR #GHHManifesto
-
-
Global Heart Hub is delighted to today launch the first patient-led global manifesto calling for early detection and diagnosis of cardiovascular disease. “Achieving early detection and diagnosis of cardiovascular disease: A manifesto for change” was developed by Global Heart Hub via a multi-stakeholder approach, bringing together 125 patient advocates including 40 cardiovascular disease patient organisations, key opinion leaders and multidisciplinary experts from across the world. The landmark manifesto calls on policymakers to implement eight practical evidence-based actions to ensure early detection and diagnosis of cardiovascular disease. Learn more - https://lnkd.in/gMyRDXYR #GHHManifesto
-
#Prevention is infinitely better than cure! Thank you, to so many, for collaborating on this important international consensus on the importance and efficacy of #earlydetection and #earlydiagnosis of #heart-diseases. The consequences of missed or delayed #diagnosis can have profound implications. #ASCVD #HeartValveDisease #HeartFailure #Hypertension #Cardiomyopathy #AtrialFibrillation #FH #LP(a) World Heart Federation European Society of Cardiology European Alliance for Cardiovascular Health (EACH) National Forum for Heart Disease & Stroke Prevention European Atherosclerosis Society American College of Cardiology American Association of Heart Failure Nurses American Heart Association
Global Heart Hub is delighted to today launch the first patient-led global manifesto calling for early detection and diagnosis of cardiovascular disease. “Achieving early detection and diagnosis of cardiovascular disease: A manifesto for change” was developed by Global Heart Hub via a multi-stakeholder approach, bringing together 125 patient advocates including 40 cardiovascular disease patient organisations, key opinion leaders and multidisciplinary experts from across the world. The landmark manifesto calls on policymakers to implement eight practical evidence-based actions to ensure early detection and diagnosis of cardiovascular disease. Learn more - https://lnkd.in/gMyRDXYR #GHHManifesto
-
The first patient-led global manifesto calling for early detection and diagnosis of cardiovascular disease is available now, and Heart Valve Voice Canada was delighted to contribute! “Achieving early detection and diagnosis of cardiovascular disease: A manifesto for change” was developed by Global Heart Hub - via a multi-stakeholder approach, bringing together 125 patient advocates including 40 cardiovascular disease patient organisations, key opinion leaders and multidisciplinary experts from across the world. Heart valve disease is a serious cardiovascular condition which can be fatal if left untreated, yet as many as half of all heart valve disease cases in people over 65 years may be going undetected in routine primary care. The landmark manifesto calls on policymakers to implement eight practical evidence-based actions to ensure early detection and diagnosis of cardiovascular disease. Learn more – https://lnkd.in/g8piYdKW #GHHManifesto Canadian Cardiovascular Society
-
Earlier this week with our partners, we announced the #TRANSFORMtrial, a groundbreaking study aimed at revolutionizing the diagnosis and prevention of heart disease. This randomized control trial, sponsored by Cleerly, aims to prove that an AI-powered, personalized care strategy that evaluates actual heart disease, atherosclerosis, is more effective at preventing #cardiovascular events than diagnosis based on traditional cardiovascular risk factors. Learn more here: https://bit.ly/479YYaY #CardiacCare
-
-
#Oralhealth is an essential component of overall health, and poor oral health has been linked to a range of systemic diseases, including cardiovascular disease, diabetes, respiratory infections, and cancer. This important field will be presented at the Lisbon Summit, and I am delighted to announce Dr. Miguel Stanley will join the lineup Speakers of the upcoming the Longevity Med Summit to be held in Lisbon on May 8-9, 2024, to present his lecture on "“Immune Dentistry and how the early detection and treatment of oral inflammation can boost systemic health” is unmissable!! #longevity #longevityclinics #longevitymedsummit #whiteclinic
-
Preventive Cardiology and CV Innovation, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School. Editor-in-Chief, Harvard Heart Letter, CPC Clinical Research 🇺🇦
The TRANSFORM trial explores a new strategy for primary prevention. Currently we just manage numbers - BP, LDL cholesterol and HbA1c for DM. The new strategy being tested uses @Cleerly imaging to evaluate extent of coronary disease, and then tailors therapy to what is seen, wiht increasing intensity for worse imaged disease. It is a strategy trial - that will see if CV event rates can be reduced with the personalized imaging-based strategy.
CPC is pleased to announce the TRANSFORM trial, a groundbreaking randomized trial to evaluate personalized heart disease care strategies. CPC is very proud to be a partner in this cutting-edge trial. This trial aims to enroll 7,500 patients without symptoms of heart disease to explore how a personalized care strategy, based on a Cleerly analysis, can revolutionize the prevention of cardiovascular events. With our partners, we are committed to advancing evidence for the evaluation and treatment of heart disease, and we are excited to collaborate on this important effort. #CardiacCare
-
In the latest President's Message, George D. Dangas, MD, PhD, MSCAI, highlights milestones toward the establishment of an independent Cardiovascular Disease Board, SCAI's revitalized governance structure, the Get a Pulse on PAD campaign, and more. ➡️Read the message: https://lnkd.in/en6NErhR
-
-
President-Elect, American College of Lifestyle Medicine, Primary Care Internist, Healthcare Transformation Strategist and Consultant, Vice President, World Lifestyle Medicine Organization
Check out the American Heart Association's new cardiovascular disease risk calculator! This tool is designed for all adults aged 30 to 79 without known cardiovascular disease and is based on a larger, more diverse sample than the existing tool. Access it now at https://lnkd.in/gAjSEDPn. #hearthealth #healthylifestyle #prevention #lifestylemedicine
PREVENTTM Online Calculator
professional.heart.org
-
Achieving early detection and diagnosis for cardiovascular disease: A manifesto for change The first patient-led global manifesto calling for early detection and diagnosis of cardiovascular disease is available now, and the Panhellenic Heart Disease Association was delighted to contribute! “Achieving early detection and diagnosis of cardiovascular disease: A manifesto for change” was developed by Global Heart Hub - via a multi-stakeholder approach, bringing together 125 patient advocates including 40 cardiovascular disease patient organisations, key opinion leaders and multidisciplinary experts from across the world. The landmark manifesto calls on policymakers to implement eight practical evidence-based actions to ensure early detection and diagnosis of cardiovascular disease. Learn more - https://lnkd.in/en8VVcZJ #GHHManifesto
